Corporates Varner and Gjensidige are among the limited partners for Hadean Ventures' first fund, which will back European life sciences startups.
Textiles retailer Varner and Gjensidigestiftelsen, the foundation that controls insurance provider Gjensidige, have contributed to the €100m ($119m) first fund for Norway-based, life sciences-focused venture capital firm Hadean Ventures.
Pension fund Oslo Pensjonsforsikring and SamInvest, a VC arm of Sweden state-owned investment fund Almi Företagspartner, also provided capital while growth equity firm Argentum invested approximately $19m in September this year.
The fund will focus on investing in life sciences technology developers located in areas of Europe underserved by venture capitalists,…
